3rd Jan 2012 15:50
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.
On 30 December 2011, the Company's Non-Executive Directors were provisionally allocated awards over Ordinary shares at a price of £14.70 per Ordinary share and $45.53 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2011 to 30 December 2011:
Non Executive Director | Ordinary Shares | American Depositary Shares (ADSs) |
Sir Christopher Gent | 2,295.918 | |
Prof. Sir Roy Anderson | 573.980 | |
325.294 | ||
Dr Stephanie Burns | ||
Ms Stacey Cartwright | 318.878 | |
Mr Lawrence Culp | 650.588 | |
Sir Crispin Davis | 2,125.850 | |
Ms Judy Lewent | 503.763 | |
Sir Deryck Maughan | 650.588 | |
Mr James Murdoch | 1,275.510 | |
Dr Daniel Podolsky | 683.117 | |
Mr Tom de Swaan | 786.565 | |
Sir Robert Wilson | 573.980 |
The Company and the Non-Executive Directors were informed of these allocations on
3 January 2012.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
3 January 2012
Related Shares:
Glaxosmithkline